<VariationArchive RecordType="classified" VariationID="31083" VariationName="NC_000012.12:g.(?_63558913)_(63669201_?)del" VariationType="Deletion" Accession="VCV000031083" Version="3" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-15" DateCreated="2022-04-08" MostRecentSubmission="2022-04-08">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="40040" VariationID="31083">
      <GeneList>
        <Gene Symbol="DPY19L2" FullName="dpy-19 like 2" GeneID="283417" HGNC_ID="HGNC:19414" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>12q14.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="63558913" stop="63668805" display_start="63558913" display_stop="63668805" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="63952692" stop="64062353" display_start="63952692" display_stop="64062353" Strand="-" />
          </Location>
          <OMIM>613893</OMIM>
        </Gene>
        <Gene Symbol="LOC130008194" FullName="ATAC-STARR-seq lymphoblastoid active region 6585" GeneID="130008194" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>12q14.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="63668390" stop="63668449" display_start="63668390" display_stop="63668449" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NC_000012.12:g.(?_63558913)_(63669201_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q14.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" innerStart="63558913" innerStop="63669201" display_start="63558913" display_stop="63669201" variantLength="110289" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" innerStart="63952693" innerStop="64062354" display_start="63952693" display_stop="64062354" variantLength="109662" />
      </Location>
      <OtherNameList>
        <Name>DPY19L2, DEL</Name>
        <Name>DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.(?_63952693)_(64062354_?)del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.(?_63952693)_(64062354_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.(?_63558913)_(63669201_?)del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.(?_63558913)_(63669201_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="613893.0001" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided the representation of the location of this deletion based on the location of DPY19L2. The likely breakpoints are in LCR regions on each side of the gene.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000012.12:g.(?_63558913)_(63669201_?)del AND Spermatogenic failure 9" Accession="RCV000024079" Version="6">
        <ClassifiedConditionList TraitSetID="7512">
          <ClassifiedCondition DB="MedGen" ID="C3151407">Spermatogenic failure 9</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-08-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2012-08-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-04-08" MostRecentSubmission="2022-04-08">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15533374</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21397063</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21397064</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22653751</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7512" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16089" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Spermatogenic failure 9</ElementValue>
                <XRef ID="Spermatogenic+failure+9/9328" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013505" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLOBOZOOSPERMIA, TOTAL</ElementValue>
                <XRef Type="MIM" ID="613958" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLOBOZOOSPERMIA, COMPLETE</ElementValue>
                <XRef Type="MIM" ID="613958" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SPGF9</ElementValue>
                <XRef Type="MIM" ID="613958" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15735" />
                <XRef ID="15735" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="171709" DB="Orphanet" />
              <XRef ID="C3151407" DB="MedGen" />
              <XRef ID="MONDO:0013505" DB="MONDO" />
              <XRef Type="MIM" ID="613958" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="50626" SubmissionDate="2022-04-05" DateLastUpdated="2022-04-08" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="613893.0001_SPERMATOGENIC FAILURE 9" title="DPY19L2, DEL_SPERMATOGENIC FAILURE 9" />
        <ClinVarAccession Accession="SCV000045370" DateUpdated="2022-04-08" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-08-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 5 infertile brothers from a consanguineous Jordanian family originally studied by Kilani et al. (2004), who had complete globozoospermia mapping to chromosome 12 (SPGF9; 613958), Koscinski et al. (2011) identified homozygosity for an approximately 200-kb deletion encompassing only the DPY19L2 gene. The DPY19L2 deletion was then screened in 24 globozoospermic patients from 20 unrelated families, and similar deletions of DPY19L2 were identified in 4 patients from 3 families: a French patient who had breakpoints identical to those of the Jordanian brothers, 2 Algerian brothers with different breakpoints, and another French patient who was a heterozygous composite, with both sets of breakpoints observed. Because the deletion was found in patients of 3 different origins with 2 different breakpoints, Koscinski et al. (2011) suggested that the deletion results from recurrent events related to specific architectural features of this locus rather than from a founder effect. Deletion of DPY19L2 was not detected in the homozygous state in 105 men of European origin or in 101 fertile Jordanian men.</Attribute>
              <Citation>
                <ID Source="PubMed">15533374</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">21397063</ID>
              </Citation>
              <XRef DB="OMIM" ID="613958" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 9 probands with globozoospermia mapping to 12q14.2 and in the globozoospermic brother of 1 of the probands, Harbuz et al. (2011) identified homozygosity for deletion of DPY19L2 in 8 of the patients, including the 2 affected brothers. Analysis of DPY19L2 in an additional 10 globozoospermic probands revealed 7 more patients with a homozygous deletion of DPY19L2. Amplification on each side of the gene revealed 2 breakpoint zones in a 15-kb region included in two 28-kb low copy repeat (LCR) sequences with 97% identity, located on each side of DPY19L2, indicating that the identified deletions were probably the result of nonallelic homologous recombination. The deletions, which encompassed approximately 200 kb and harbored only the DPY19L2 gene, had the same breakpoint localizations in all 15 patients, with the minimal deleted region spanning 22.3 kb and corresponding to a breakpoint ranging from 62,342,196 to 62,364,496 (NCBI36). Of the 15 patients with the deletion, 12 were Tunisian in origin, 2 were Moroccan, and 1 was Algerian. Harbuz et al. (2011) stated that because of the presence of duplicated DPY19 sequences, including DPY19L2P1 on chromosome 7 which has greater than 95% sequence identity with DPY19L2, it was extremely difficult to identify primers and amplification conditions specific to DPY19L2 and they had not been able to sequence the gene in totality; however, PCR amplification of exons 1 and 11 in 200 fertile North African men and 100 fertile European men indicated that none was homozygous for the DPY19L2 deletion.</Attribute>
              <Citation>
                <ID Source="PubMed">21397064</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 21 unrelated men with globozoospermia from Iran, Turkey, Saudi Arabia, Morocco, and Belgium, Elinati et al. (2012) identified homozygosity for deletion of DPY19L2. In another 7 globozoospermic probands, including 2 patients previously studied by Koscinski et al. (2011), Elinati et al. (2012) identified compound heterozygosity for deletion of DPY19L2 and another mutation (see, e.g., 613893.0002-613893.0005). The authors defined 9 different breakpoints for the DPY19L2 deletion, 6 of which were recurrent; all recurrent breakpoints were found among patients originating from different regions, and patients from the same country showed different breakpoints. The mechanism underlying the deletion is nonallelic homologous recombination between flanking low-copy repeats.</Attribute>
              <Citation>
                <ID Source="PubMed">22653751</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">21397063</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DPY19L2" />
          </GeneList>
          <Name>DPY19L2, DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="613893.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SPERMATOGENIC FAILURE 9</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="50626" TraitType="Disease" MappingType="Name" MappingValue="SPERMATOGENIC FAILURE 9" MappingRef="Preferred">
        <MedGen CUI="C3151407" Name="Spermatogenic failure 9" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

